R.D. Snyder
DuPont Pharmaceuticals
Stine-Haskell Research Center
Newark
Delaware 19714-0030
USA
Name/email consistency: high
- A review of the genotoxicity of marketed pharmaceuticals. Snyder, R.D., Green, J.W. Mutat. Res. (2001)
- Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells. Snyder, R.D. Environ. Mol. Mutagen. (2000)
- Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II. Snyder, R.D., Grdina, D.J. Cancer Res. (2000)









